Ashkenazi A, Young WB The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 2005 Apr;45(4):350-4.
Ay S, Evcik D, Tur BS Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol. 2010 Jan;29(1):19-23. doi: 10.1007/s10067-009-1307-8. Epub 2009 Oct 20.
Benecke R, Heinze A, Reichel G, Hefter H, Göbel H; Dysport myofascial pain study group Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Pain Med. 2011 Nov;12(11):1607-14. doi: 10.1111/j.1526-4637.2011.01163.x. Epub 2011 Jun 21.
Choi JW, Lee CJ, Lee SM, Shin BS, Jun B, Sim WS Effect of Hyaluronidase Addition to Lidocaine for Trigger Point Injection in Myofascial Pain Syndrome. Pain Pract. 2016 Nov;16(8):1019-1026. doi: 10.1111/papr.12362. Epub 2015 Oct 7.
Cleeland CS, Ryan KM Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38. Review.
Cotchett MP, Landorf KB, Munteanu SE Effectiveness of dry needling and injections of myofascial trigger points associated with plantar heel pain: a systematic review. J Foot Ankle Res. 2010 Sep 1;3:18. doi: 10.1186/1757-1146-3-18.
De Andrés J, Adsuara VM, Palmisani S, Villanueva V, López-Alarcón MD A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. Reg Anesth Pain Med. 2010 May-Jun;35(3):255-60. doi: 10.1097/AAP.0b013e3181d23241.
Desai MJ, Saini V, Saini S Myofascial pain syndrome: a treatment review. Pain Ther. 2013 Jun;2(1):21-36. doi: 10.1007/s40122-013-0006-y. Epub 2013 Feb 12.
Drewes AM, Andreasen A, Poulsen LH Injection Therapy for Treatment of Chronic Myofascial Pain. J Musculoskelet Pain. 2010;1(3-4):289-294.
Frost A Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol. 1986;15(2):153-6.
Frost FA, Jessen B, Siggaard-Andersen J A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet. 1980 Mar 8;1(8167):499-500.
Ga H, Koh HJ, Choi JH, Kim CH Intramuscular and nerve root stimulation vs lidocaine injection to trigger points in myofascial pain syndrome. J Rehabil Med. 2007 May;39(5):374-8.
Garvey TA, Marks MR, Wiesel SW A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine (Phila Pa 1976). 1989 Sep;14(9):962-4.
Göbel H, Heinze A, Reichel G, Hefter H, Benecke R; Dysport myofascial pain study group Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006 Nov;125(1-2):82-8. Epub 2006 Jun 5.
Hong CZ Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994 Jul-Aug;73(4):256-63.
Karadas Ö, Gül HL, Inan LE Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension-type headache. J Headache Pain. 2013 May 22;14:44. doi: 10.1186/1129-2377-14-44.
Kietrys DM, Palombaro KM, Mannheimer JS Dry needling for management of pain in the upper quarter and craniofacial region. Curr Pain Headache Rep. 2014;18(8):437. doi: 10.1007/s11916-014-0437-0. Review.
Kim DH, Yoon DM, Yoon KB The effects of myofascial trigger point injections on nocturnal calf cramps. J Am Board Fam Med. 2015 Jan-Feb;28(1):21-7. doi: 10.3122/jabfm.2015.01.140151.
Krishnan SK, Benzon HT, Siddiqui T, Canlas B Pain on intramuscular injection of bupivacaine, ropivacaine, with and without dexamethasone. Reg Anesth Pain Med. 2000 Nov-Dec;25(6):615-9.
Liu L, Huang QM, Liu QG, Ye G, Bo CZ, Chen MJ, Li P Effectiveness of dry needling for myofascial trigger points associated with neck and shoulder pain: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015 May;96(5):944-55. doi: 10.1016/j.apmr.2014.12.015. Epub 2015 Jan 7. Review.
McMillan AS, Nolan A, Kelly PJ The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles. J Orofac Pain. 1997 Fall;11(4):307-14.
Misirlioglu TO, Akgun K, Palamar D, Erden MG, Erbilir T Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a double-blinded, randomized controlled study. Pain Physician. 2015 Mar-Apr;18(2):163-71.
Ojala T, Arokoski JP, Partanen J The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Clin J Pain. 2006 Jan;22(1):90-6.
Shah JP, Phillips TM, Danoff JV, Gerber LH An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol (1985). 2005 Nov;99(5):1977-84. Epub 2005 Jul 21.
Shirokov VA, Potaturko AV, Zakharov IaIu [Safety and efficacy of movalis injected into trigger points in lumbago-ischialgia syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(9):41-4. Russian.
Simons DG, Travell JG, Simons LS Travell & Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual. Upper half of body. Vol. 1. Vol 1: Wolters Kluwer Health; 1999.
Soares A, Andriolo RB, Atallah AN, da Silva EM Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev. 2014 Jul 25;(7):CD007533. doi: 10.1002/14651858.CD007533.pub3. Review.
Sternfeld M, Finkelstein Y, Hai E, Hod I Tension headache treated by anti-inflammatory drug injected into GB 20 acupuncture point. Am J Chin Med. 1986;14(3-4):171-4.
Tekin L, Akarsu S, Durmus O, Cakar E, Dinçer U, Kiralp MZ The effect of dry needling in the treatment of myofascial pain syndrome: a randomized double-blinded placebo-controlled trial. Clin Rheumatol. 2013 Mar;32(3):309-15. doi: 10.1007/s10067-012-2112-3. Epub 2012 Nov 9.
Tschopp KP, Gysin C Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck. ORL J Otorhinolaryngol Relat Spec. 1996 Nov-Dec;58(6):306-10.
Venâncio Rde A, Alencar FG, Zamperini C Different substances and dry-needling injections in patients with myofascial pain and headaches. Cranio. 2008 Apr;26(2):96-103.
Wheeler AH, Goolkasian P, Gretz SS A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine (Phila Pa 1976). 1998 Aug 1;23(15):1662-6; discussion 1667.
Xie P, Qin B, Yang F, Yu T, Yu J, Wang J, Zheng H Lidocaine Injection in the Intramuscular Innervation Zone Can Effectively Treat Chronic Neck Pain Caused by MTrPs in the Trapezius Muscle. Pain Physician. 2015 Sep-Oct;18(5):E815-26.
Yamaguchi A, Ogino Y, Iwakoshi C, Karasawa K, Ohki M [Trigger point therapy for myofascial pain in cancer patients (second report) analysis results of special use-results surveillance by neovitacain® injection]. Gan To Kagaku Ryoho. 2012 Apr;39(4):605-11. Japanese.
Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.